The global syphilis testing market size was valued at USD 556.70 million in 2025 and is projected to reach USD 1,509.15 million by 2034, growing at a CAGR of 11.76% during the forecast period.

The global syphilis testing market is witnessing substantial growth due to increasing awareness regarding sexually transmitted infections (STIs), rising adoption of point-of-care diagnostic solutions, and growing implementation of community-based screening programs. The demand for accurate and rapid syphilis diagnosis is accelerating across hospitals, laboratories, and healthcare centers worldwide, creating favorable growth opportunities for market participants.

Market Highlights

• Market Size in 2025: USD 556.70 Million
• Projected Market Size by 2034: USD 1,509.15 Million
• CAGR (2026–2034): 11.76%
• Largest Regional Market: North America (42.23% market share in 2025)
• Fastest Growing Region: Asia-Pacific (CAGR of 13.76%)
• Fastest Growing Type Segment: Primary Syphilis (CAGR of 12.12%)
• Largest Test Type Segment: Treponemal Immunoassays (TPPA, TPHA) (35.63% share in 2025)
• Largest Technology Segment: Immunoassay (45.64% share in 2025)
• Fastest Growing Location of Testing Segment: Point-of-Care Testing (CAGR of 12.67%)

Market Dynamics

Driver

The syphilis testing market is being driven by the increasing adoption of integrated testing pathways that combine rapid screening with laboratory-based confirmatory diagnostics. Healthcare providers and public health organizations are increasingly emphasizing early disease detection to reduce transmission rates and improve treatment outcomes. Growing screening initiatives among high-risk populations, pregnant women, and community healthcare programs are significantly increasing testing volumes worldwide.

Furthermore, the expansion of point-of-care testing technologies is improving accessibility to syphilis diagnosis, particularly in underserved and remote regions. Rapid diagnostic tests offer quick results, enabling timely treatment decisions and reducing the burden on healthcare systems. These advancements are contributing to broader market penetration and improved disease surveillance.

Restraint

Despite strong growth prospects, the market faces challenges related to incomplete follow-up testing after initial screening. Many individuals fail to undergo confirmatory testing due to limited awareness, logistical barriers, or inadequate healthcare access. This can delay diagnosis and treatment while impacting the overall effectiveness of screening programs.

In addition, variations in healthcare infrastructure across developing regions may limit access to advanced testing technologies. Budget constraints and shortages of trained laboratory professionals can further restrict widespread adoption of sophisticated diagnostic solutions.

Opportunity

The growing establishment of community-based syphilis awareness and screening centers presents a significant opportunity for market expansion. These facilities offer walk-in testing services, educational programs, and referral networks that improve access to routine screening and early diagnosis.

Moreover, increasing government support for STI prevention programs and investments in public health infrastructure are expected to strengthen diagnostic capabilities globally. The integration of digital health platforms and telehealth services is also creating new opportunities for patient engagement, awareness, and testing accessibility.

Top Market Players

• Hoffmann-La Roche Ltd.
• Abbott
• BD
• Siemens Healthineers AG
• BIOMÉRIEUX
• Hologic, Inc.
• Cepheid
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• QuidelOrtho Corporation
• Trinity Biotech
• SD Biosensor, Inc.
• Arlington Scientific
• DiaSorin S.p.A.
• Beckman Coulter, Inc.
• bioLytical Laboratories Inc.

Market Segmentation

By Type

• Primary Syphilis
• Secondary Syphilis

By Test Type

• Non-treponemal Tests (RPR, VDRL)
• Treponemal Immunoassays (TPPA, TPHA)
• Enzyme Immunoassays (ELISA) & Chemiluminescent Immunoassays (CLIA)
• Rapid Diagnostic Tests (Lateral Flow Immunoassays)
• Molecular Tests (PCR/NAAT)
• Multiplex STI Panels Including Syphilis Targets

By Technology

• Molecular Diagnostics
• Immunoassay
• Others

By Location of Testing

• Laboratory Testing
• Point-of-Care Testing

By Region

• North America
• Europe
• Asia-Pacific
• Middle East & Africa
• Latin America

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/syphilis-testing-market

Gain comprehensive market intelligence, competitive benchmarking, growth opportunities, emerging trends, and strategic recommendations with the full Syphilis Testing Market report from Straits Research.

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights and market research reports.

Contact Us

Email: sales@straitsresearch.com

U.S. Tel: +1 646 905 0080

U.K. Tel: +44 203 695 0070